Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $1.74 billion. The enterprise value is $2.95 billion.
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 35.96 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 35.96M |
| Shares Outstanding | 35.96M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.77% |
| Owned by Institutions (%) | 103.22% |
| Float | 35.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.05 |
| PS Ratio | 1.26 |
| Forward PS | 1.31 |
| PB Ratio | 12.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.27 |
| P/OCF Ratio | 5.84 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.38, with an EV/FCF ratio of 12.32.
| EV / Earnings | n/a |
| EV / Sales | 2.14 |
| EV / EBITDA | 8.38 |
| EV / EBIT | 11.54 |
| EV / FCF | 12.32 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 9.35.
| Current Ratio | 1.27 |
| Quick Ratio | 0.63 |
| Debt / Equity | 9.35 |
| Debt / EBITDA | 3.46 |
| Debt / FCF | 5.39 |
| Interest Coverage | 2.99 |
Financial Efficiency
Return on equity (ROE) is -204.65% and return on invested capital (ROIC) is 9.98%.
| Return on Equity (ROE) | -204.65% |
| Return on Assets (ROA) | 7.90% |
| Return on Invested Capital (ROIC) | 9.98% |
| Return on Capital Employed (ROCE) | 17.98% |
| Revenue Per Employee | $863,813 |
| Profits Per Employee | -$41,188 |
| Employee Count | 1,600 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 4.04 |
Taxes
| Income Tax | -46.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.43% in the last 52 weeks. The beta is 1.40, so Ingevity's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +5.43% |
| 50-Day Moving Average | 54.02 |
| 200-Day Moving Average | 46.66 |
| Relative Strength Index (RSI) | 40.66 |
| Average Volume (20 Days) | 303,825 |
Short Selling Information
The latest short interest is 871,370, so 2.42% of the outstanding shares have been sold short.
| Short Interest | 871,370 |
| Short Previous Month | 927,620 |
| Short % of Shares Out | 2.42% |
| Short % of Float | 2.44% |
| Short Ratio (days to cover) | 4.80 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.38 billion and -$65.90 million in losses. Loss per share was -$1.82.
| Revenue | 1.38B |
| Gross Profit | 463.50M |
| Operating Income | 255.70M |
| Pretax Income | -407.70M |
| Net Income | -65.90M |
| EBITDA | 352.20M |
| EBIT | 255.70M |
| Loss Per Share | -$1.82 |
Full Income StatementBalance Sheet
The company has $83.40 million in cash and $1.29 billion in debt, giving a net cash position of -$1.21 billion or -$33.60 per share.
| Cash & Cash Equivalents | 83.40M |
| Total Debt | 1.29B |
| Net Cash | -1.21B |
| Net Cash Per Share | -$33.60 |
| Equity (Book Value) | 138.10M |
| Book Value Per Share | 3.83 |
| Working Capital | 110.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $298.60 million and capital expenditures -$59.00 million, giving a free cash flow of $239.60 million.
| Operating Cash Flow | 298.60M |
| Capital Expenditures | -59.00M |
| Free Cash Flow | 239.60M |
| FCF Per Share | $6.66 |
Full Cash Flow StatementMargins
Gross margin is 33.54%, with operating and profit margins of 18.50% and -4.77%.
| Gross Margin | 33.54% |
| Operating Margin | 18.50% |
| Pretax Margin | -29.50% |
| Profit Margin | -4.77% |
| EBITDA Margin | 25.48% |
| EBIT Margin | 18.50% |
| FCF Margin | 17.34% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.22% |
| Shareholder Yield | -0.22% |
| Earnings Yield | -3.78% |
| FCF Yield | 13.75% |
Dividend DetailsAnalyst Forecast
The average price target for Ingevity is $61.50, which is 26.78% higher than the current price. The consensus rating is "Buy".
| Price Target | $61.50 |
| Price Target Difference | 26.78% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 2.23 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.23 |
| Piotroski F-Score | 5 |
